Targeted Imaging of Lung Cancer with Hyperpolarized 129Xe MRI Using Surface-Modified Iron Oxide Nanoparticles as Molecular Contrast Agents

Hyperpolarized 129Xe (HP 129Xe) MRI enables functional imaging of various lung diseases but has been scarcely applied to lung cancer imaging. The aim of this study is to investigate the feasibility of targeted imaging of lung cancer with HP 129Xe MRI using surface-modified iron oxide nanoparticles (...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancers 2022-12, Vol.14 (24), p.6070
Hauptverfasser: Kimura, Atsuomi, Utsumi, Seiya, Shimokawa, Akihiro, Nishimori, Renya, Hosoi, Rie, Stewart, Neil J., Imai, Hirohiko, Fujiwara, Hideaki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 24
container_start_page 6070
container_title Cancers
container_volume 14
creator Kimura, Atsuomi
Utsumi, Seiya
Shimokawa, Akihiro
Nishimori, Renya
Hosoi, Rie
Stewart, Neil J.
Imai, Hirohiko
Fujiwara, Hideaki
description Hyperpolarized 129Xe (HP 129Xe) MRI enables functional imaging of various lung diseases but has been scarcely applied to lung cancer imaging. The aim of this study is to investigate the feasibility of targeted imaging of lung cancer with HP 129Xe MRI using surface-modified iron oxide nanoparticles (IONPs) as molecular targeting contrast agents. A mouse model of lung cancer (LC) was induced in nine mice by intra-peritoneal injection of urethane. Three months after the urethane administration, the mice underwent lung imaging with HP 129Xe MRI at baseline (0 h). Subsequently, the LC group was divided into two sub-groups: mice administered with polyethylene glycol-coated IONPs (PEG-IONPs, n = 4) and folate-conjugated dextran-coated IONPs (FA@Dex-IONPs, n = 5). The mice were imaged at 3, 6, and 24 h after the intravenous injection of IONPs. FA@Dex-IONPs mice showed a 25% reduction in average signal intensity at cancer sites at 3 h post injection, and a 24% reduction at 24 h post injection. On the other hand, in PEG-IONPs mice, while a signal reduction of approximately 28% was observed at cancer sites at 3 to 6 h post injection, the signal intensity was unchanged from that of the baseline at 24 h. Proton MRI of LC mice (n = 3) was able to detect cancer five months after urethane administration, i.e., later than HP 129Xe MRI (3 months). Furthermore, a significant decrease in averaged 1H T2 values at cancer sites was observed at only 6 h post injection of FA@Dex-IONPs (p < 0.05). As such, the targeted delivery of IONPs to cancer tissue was successfully imaged with HP 129Xe MRI, and their surface modification with folate likely has a high affinity with LC, which causes overexpression of folate receptors.
doi_str_mv 10.3390/cancers14246070
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9776850</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2758102148</sourcerecordid><originalsourceid>FETCH-LOGICAL-c328t-56ef067cb4f0f87928fb9d948c3fe59ad5a3895268c1d3998b86d943f559263d3</originalsourceid><addsrcrecordid>eNpdkU1r3DAQQE1poCHJOVdBL724kSXr61IIS9ss7DbQJJCb0MojR8EruZLdNv0J_dWRm1DazGUG5s1jhqmq0wa_p1ThM2uChZSblrQcC_yqOiRYkJpz1b7-p35TneR8j0tQ2gguDqvf1yb1MEGH1nvT-9Cj6NBmLnn1R4l--OkOXTyMkMY4mOR_FbQh6hbQ9usa3eRl5GpOzliot7Hzzi-uFAO6_Ok7QF9MiKNJk7cDZGQy2sYB7FxUaBXDlEye0HkPYcrH1YEzQ4aT53xU3Xz6eL26qDeXn9er801tKZFTzTg4zIXdtQ47KRSRbqc61UpLHTBlOmaoVIxwaZuOKiV3kpc2dYwpwmlHj6oPT95x3u2hs7BsMegx-b1JDzoar__vBH-n-_hdKyG4ZLgI3j0LUvw2Q5703mcLw2ACxDlrIphsMGlaWdC3L9D7OKdQzlsozouPqUKdPVE2xZwTuL_LNFgv_9Uv_ksfAVd6m08</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2756668559</pqid></control><display><type>article</type><title>Targeted Imaging of Lung Cancer with Hyperpolarized 129Xe MRI Using Surface-Modified Iron Oxide Nanoparticles as Molecular Contrast Agents</title><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Kimura, Atsuomi ; Utsumi, Seiya ; Shimokawa, Akihiro ; Nishimori, Renya ; Hosoi, Rie ; Stewart, Neil J. ; Imai, Hirohiko ; Fujiwara, Hideaki</creator><creatorcontrib>Kimura, Atsuomi ; Utsumi, Seiya ; Shimokawa, Akihiro ; Nishimori, Renya ; Hosoi, Rie ; Stewart, Neil J. ; Imai, Hirohiko ; Fujiwara, Hideaki</creatorcontrib><description>Hyperpolarized 129Xe (HP 129Xe) MRI enables functional imaging of various lung diseases but has been scarcely applied to lung cancer imaging. The aim of this study is to investigate the feasibility of targeted imaging of lung cancer with HP 129Xe MRI using surface-modified iron oxide nanoparticles (IONPs) as molecular targeting contrast agents. A mouse model of lung cancer (LC) was induced in nine mice by intra-peritoneal injection of urethane. Three months after the urethane administration, the mice underwent lung imaging with HP 129Xe MRI at baseline (0 h). Subsequently, the LC group was divided into two sub-groups: mice administered with polyethylene glycol-coated IONPs (PEG-IONPs, n = 4) and folate-conjugated dextran-coated IONPs (FA@Dex-IONPs, n = 5). The mice were imaged at 3, 6, and 24 h after the intravenous injection of IONPs. FA@Dex-IONPs mice showed a 25% reduction in average signal intensity at cancer sites at 3 h post injection, and a 24% reduction at 24 h post injection. On the other hand, in PEG-IONPs mice, while a signal reduction of approximately 28% was observed at cancer sites at 3 to 6 h post injection, the signal intensity was unchanged from that of the baseline at 24 h. Proton MRI of LC mice (n = 3) was able to detect cancer five months after urethane administration, i.e., later than HP 129Xe MRI (3 months). Furthermore, a significant decrease in averaged 1H T2 values at cancer sites was observed at only 6 h post injection of FA@Dex-IONPs (p &lt; 0.05). As such, the targeted delivery of IONPs to cancer tissue was successfully imaged with HP 129Xe MRI, and their surface modification with folate likely has a high affinity with LC, which causes overexpression of folate receptors.</description><identifier>ISSN: 2072-6694</identifier><identifier>EISSN: 2072-6694</identifier><identifier>DOI: 10.3390/cancers14246070</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Acids ; Aqueous solutions ; Calibration ; Chronic obstructive pulmonary disease ; Clinical trials ; Coatings ; Contrast media ; Dextran ; Ethyl carbamate ; Folic acid ; Functional magnetic resonance imaging ; Gases ; Injection ; Intravenous administration ; Iron oxides ; Lung cancer ; Lung diseases ; Nanoparticles ; Nitrogen ; Pharmacokinetics ; Polyethylene glycol ; Vitamin B</subject><ispartof>Cancers, 2022-12, Vol.14 (24), p.6070</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c328t-56ef067cb4f0f87928fb9d948c3fe59ad5a3895268c1d3998b86d943f559263d3</citedby><cites>FETCH-LOGICAL-c328t-56ef067cb4f0f87928fb9d948c3fe59ad5a3895268c1d3998b86d943f559263d3</cites><orcidid>0000-0001-8358-394X ; 0000-0001-5702-276X ; 0000-0002-9720-3546</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776850/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776850/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Kimura, Atsuomi</creatorcontrib><creatorcontrib>Utsumi, Seiya</creatorcontrib><creatorcontrib>Shimokawa, Akihiro</creatorcontrib><creatorcontrib>Nishimori, Renya</creatorcontrib><creatorcontrib>Hosoi, Rie</creatorcontrib><creatorcontrib>Stewart, Neil J.</creatorcontrib><creatorcontrib>Imai, Hirohiko</creatorcontrib><creatorcontrib>Fujiwara, Hideaki</creatorcontrib><title>Targeted Imaging of Lung Cancer with Hyperpolarized 129Xe MRI Using Surface-Modified Iron Oxide Nanoparticles as Molecular Contrast Agents</title><title>Cancers</title><description>Hyperpolarized 129Xe (HP 129Xe) MRI enables functional imaging of various lung diseases but has been scarcely applied to lung cancer imaging. The aim of this study is to investigate the feasibility of targeted imaging of lung cancer with HP 129Xe MRI using surface-modified iron oxide nanoparticles (IONPs) as molecular targeting contrast agents. A mouse model of lung cancer (LC) was induced in nine mice by intra-peritoneal injection of urethane. Three months after the urethane administration, the mice underwent lung imaging with HP 129Xe MRI at baseline (0 h). Subsequently, the LC group was divided into two sub-groups: mice administered with polyethylene glycol-coated IONPs (PEG-IONPs, n = 4) and folate-conjugated dextran-coated IONPs (FA@Dex-IONPs, n = 5). The mice were imaged at 3, 6, and 24 h after the intravenous injection of IONPs. FA@Dex-IONPs mice showed a 25% reduction in average signal intensity at cancer sites at 3 h post injection, and a 24% reduction at 24 h post injection. On the other hand, in PEG-IONPs mice, while a signal reduction of approximately 28% was observed at cancer sites at 3 to 6 h post injection, the signal intensity was unchanged from that of the baseline at 24 h. Proton MRI of LC mice (n = 3) was able to detect cancer five months after urethane administration, i.e., later than HP 129Xe MRI (3 months). Furthermore, a significant decrease in averaged 1H T2 values at cancer sites was observed at only 6 h post injection of FA@Dex-IONPs (p &lt; 0.05). As such, the targeted delivery of IONPs to cancer tissue was successfully imaged with HP 129Xe MRI, and their surface modification with folate likely has a high affinity with LC, which causes overexpression of folate receptors.</description><subject>Acids</subject><subject>Aqueous solutions</subject><subject>Calibration</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Clinical trials</subject><subject>Coatings</subject><subject>Contrast media</subject><subject>Dextran</subject><subject>Ethyl carbamate</subject><subject>Folic acid</subject><subject>Functional magnetic resonance imaging</subject><subject>Gases</subject><subject>Injection</subject><subject>Intravenous administration</subject><subject>Iron oxides</subject><subject>Lung cancer</subject><subject>Lung diseases</subject><subject>Nanoparticles</subject><subject>Nitrogen</subject><subject>Pharmacokinetics</subject><subject>Polyethylene glycol</subject><subject>Vitamin B</subject><issn>2072-6694</issn><issn>2072-6694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkU1r3DAQQE1poCHJOVdBL724kSXr61IIS9ss7DbQJJCb0MojR8EruZLdNv0J_dWRm1DazGUG5s1jhqmq0wa_p1ThM2uChZSblrQcC_yqOiRYkJpz1b7-p35TneR8j0tQ2gguDqvf1yb1MEGH1nvT-9Cj6NBmLnn1R4l--OkOXTyMkMY4mOR_FbQh6hbQ9usa3eRl5GpOzliot7Hzzi-uFAO6_Ok7QF9MiKNJk7cDZGQy2sYB7FxUaBXDlEye0HkPYcrH1YEzQ4aT53xU3Xz6eL26qDeXn9er801tKZFTzTg4zIXdtQ47KRSRbqc61UpLHTBlOmaoVIxwaZuOKiV3kpc2dYwpwmlHj6oPT95x3u2hs7BsMegx-b1JDzoar__vBH-n-_hdKyG4ZLgI3j0LUvw2Q5703mcLw2ACxDlrIphsMGlaWdC3L9D7OKdQzlsozouPqUKdPVE2xZwTuL_LNFgv_9Uv_ksfAVd6m08</recordid><startdate>20221209</startdate><enddate>20221209</enddate><creator>Kimura, Atsuomi</creator><creator>Utsumi, Seiya</creator><creator>Shimokawa, Akihiro</creator><creator>Nishimori, Renya</creator><creator>Hosoi, Rie</creator><creator>Stewart, Neil J.</creator><creator>Imai, Hirohiko</creator><creator>Fujiwara, Hideaki</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-8358-394X</orcidid><orcidid>https://orcid.org/0000-0001-5702-276X</orcidid><orcidid>https://orcid.org/0000-0002-9720-3546</orcidid></search><sort><creationdate>20221209</creationdate><title>Targeted Imaging of Lung Cancer with Hyperpolarized 129Xe MRI Using Surface-Modified Iron Oxide Nanoparticles as Molecular Contrast Agents</title><author>Kimura, Atsuomi ; Utsumi, Seiya ; Shimokawa, Akihiro ; Nishimori, Renya ; Hosoi, Rie ; Stewart, Neil J. ; Imai, Hirohiko ; Fujiwara, Hideaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c328t-56ef067cb4f0f87928fb9d948c3fe59ad5a3895268c1d3998b86d943f559263d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Acids</topic><topic>Aqueous solutions</topic><topic>Calibration</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Clinical trials</topic><topic>Coatings</topic><topic>Contrast media</topic><topic>Dextran</topic><topic>Ethyl carbamate</topic><topic>Folic acid</topic><topic>Functional magnetic resonance imaging</topic><topic>Gases</topic><topic>Injection</topic><topic>Intravenous administration</topic><topic>Iron oxides</topic><topic>Lung cancer</topic><topic>Lung diseases</topic><topic>Nanoparticles</topic><topic>Nitrogen</topic><topic>Pharmacokinetics</topic><topic>Polyethylene glycol</topic><topic>Vitamin B</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kimura, Atsuomi</creatorcontrib><creatorcontrib>Utsumi, Seiya</creatorcontrib><creatorcontrib>Shimokawa, Akihiro</creatorcontrib><creatorcontrib>Nishimori, Renya</creatorcontrib><creatorcontrib>Hosoi, Rie</creatorcontrib><creatorcontrib>Stewart, Neil J.</creatorcontrib><creatorcontrib>Imai, Hirohiko</creatorcontrib><creatorcontrib>Fujiwara, Hideaki</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kimura, Atsuomi</au><au>Utsumi, Seiya</au><au>Shimokawa, Akihiro</au><au>Nishimori, Renya</au><au>Hosoi, Rie</au><au>Stewart, Neil J.</au><au>Imai, Hirohiko</au><au>Fujiwara, Hideaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Targeted Imaging of Lung Cancer with Hyperpolarized 129Xe MRI Using Surface-Modified Iron Oxide Nanoparticles as Molecular Contrast Agents</atitle><jtitle>Cancers</jtitle><date>2022-12-09</date><risdate>2022</risdate><volume>14</volume><issue>24</issue><spage>6070</spage><pages>6070-</pages><issn>2072-6694</issn><eissn>2072-6694</eissn><abstract>Hyperpolarized 129Xe (HP 129Xe) MRI enables functional imaging of various lung diseases but has been scarcely applied to lung cancer imaging. The aim of this study is to investigate the feasibility of targeted imaging of lung cancer with HP 129Xe MRI using surface-modified iron oxide nanoparticles (IONPs) as molecular targeting contrast agents. A mouse model of lung cancer (LC) was induced in nine mice by intra-peritoneal injection of urethane. Three months after the urethane administration, the mice underwent lung imaging with HP 129Xe MRI at baseline (0 h). Subsequently, the LC group was divided into two sub-groups: mice administered with polyethylene glycol-coated IONPs (PEG-IONPs, n = 4) and folate-conjugated dextran-coated IONPs (FA@Dex-IONPs, n = 5). The mice were imaged at 3, 6, and 24 h after the intravenous injection of IONPs. FA@Dex-IONPs mice showed a 25% reduction in average signal intensity at cancer sites at 3 h post injection, and a 24% reduction at 24 h post injection. On the other hand, in PEG-IONPs mice, while a signal reduction of approximately 28% was observed at cancer sites at 3 to 6 h post injection, the signal intensity was unchanged from that of the baseline at 24 h. Proton MRI of LC mice (n = 3) was able to detect cancer five months after urethane administration, i.e., later than HP 129Xe MRI (3 months). Furthermore, a significant decrease in averaged 1H T2 values at cancer sites was observed at only 6 h post injection of FA@Dex-IONPs (p &lt; 0.05). As such, the targeted delivery of IONPs to cancer tissue was successfully imaged with HP 129Xe MRI, and their surface modification with folate likely has a high affinity with LC, which causes overexpression of folate receptors.</abstract><cop>Basel</cop><pub>MDPI AG</pub><doi>10.3390/cancers14246070</doi><orcidid>https://orcid.org/0000-0001-8358-394X</orcidid><orcidid>https://orcid.org/0000-0001-5702-276X</orcidid><orcidid>https://orcid.org/0000-0002-9720-3546</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2072-6694
ispartof Cancers, 2022-12, Vol.14 (24), p.6070
issn 2072-6694
2072-6694
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9776850
source PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Acids
Aqueous solutions
Calibration
Chronic obstructive pulmonary disease
Clinical trials
Coatings
Contrast media
Dextran
Ethyl carbamate
Folic acid
Functional magnetic resonance imaging
Gases
Injection
Intravenous administration
Iron oxides
Lung cancer
Lung diseases
Nanoparticles
Nitrogen
Pharmacokinetics
Polyethylene glycol
Vitamin B
title Targeted Imaging of Lung Cancer with Hyperpolarized 129Xe MRI Using Surface-Modified Iron Oxide Nanoparticles as Molecular Contrast Agents
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T07%3A43%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Targeted%20Imaging%20of%20Lung%20Cancer%20with%20Hyperpolarized%20129Xe%20MRI%20Using%20Surface-Modified%20Iron%20Oxide%20Nanoparticles%20as%20Molecular%20Contrast%20Agents&rft.jtitle=Cancers&rft.au=Kimura,%20Atsuomi&rft.date=2022-12-09&rft.volume=14&rft.issue=24&rft.spage=6070&rft.pages=6070-&rft.issn=2072-6694&rft.eissn=2072-6694&rft_id=info:doi/10.3390/cancers14246070&rft_dat=%3Cproquest_pubme%3E2758102148%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2756668559&rft_id=info:pmid/&rfr_iscdi=true